Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 13,732	$ 17,703
Accounts receivable, net of allowance for credit losses of $2,356 and $3,225 at 2022 and 2021, respectively	100,195	96,830
Inventories	54,795	45,443
Prepaid expenses	11,514	14,059
Income taxes receivable	9,298	9,911
Other current assets	5,681	5,109
TOTAL CURRENT ASSETS	195,215	189,055
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of $313,100 and $306,461 at 2022 and 2021, respectively	107,252	110,952
RIGHT OF USE ASSETS	56,589	61,387
INTANGIBLES, net of accumulated amortization of $17,422 and $17,540 at 2022 and 2021, respectively	7,651	8,139
GOODWILL	99,445	99,445
DEFERRED TAX ASSETS, net	70,652	70,462
OTHER ASSETS	33,386	41,413
TOTAL ASSETS	570,190	580,853
CURRENT LIABILITIES:
Accounts payable	34,343	29,726
Accrued payroll and related costs	21,225	20,833
Taxes other than payroll and income	4,626	5,931
Unearned revenues	5,760	7,765
Operating lease liabilities	11,472	12,342
Income taxes payable	3,093	6,502
Other current liabilities	6,840	7,683
TOTAL CURRENT LIABILITIES	87,359	90,782
LONG-TERM DEBT, net	182,677	188,636
LONG-TERM OPERATING LEASE LIABILITIES	41,975	49,286
DEFERRED COMPENSATION	31,323	39,101
DEFERRED TAX LIABILITIES, net	22,719	24,336
OTHER LONG-TERM LIABILITIES	20,844	27,711
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 46,454,264 issued and 46,344,670 outstanding at 2022 and 46,454,264 issued and 46,349,397 outstanding at 2021	1,188	1,188
Additional paid-in capital	106,329	101,120
Retained earnings	79,662	68,349
Accumulated other comprehensive income (loss)	(4,500)	(10,133)
Treasury shares (at cost), 109,594 at 2022 and 104,867 at 2021	(4,143)	(4,075)
Total Core Laboratories N.V. shareholders' equity	178,536	156,449
Non-controlling interest	4,757	4,552
TOTAL EQUITY	183,293	161,001
TOTAL LIABILITIES AND EQUITY	$ 570,190	$ 580,853